Pietro Bernardo Dall'Aglio

Plain English
This study looked at patients who received a new type of defibrillator called a subcutaneous implantable cardioverter defibrillator (S-ICD) after their previous one (transvenous ICD, or TV-ICD) was removed due to problems like infection (64%) or lead malfunction (36%). Out of 36 patients followed for about 31 months, 8 people (22%) died, mainly from heart failure, and 7 others (19%) faced complications related to the new device. The findings show that the S-ICD is a good option for patients who need a replacement after lead extraction, with deaths primarily linked to existing health conditions rather than the new device itself. Who this helps: This helps patients requiring a defibrillator after complications from their previous device.

Plain English
This study looked at the results of 105 patients who received a subcutaneous implantable cardioverter defibrillator (S-ICD) using a specific two-incision technique over three years. The researchers found that 9.5% of patients had device-related complications and 8.5% experienced inappropriate shocks, with lead-related issues being the most frequent problems. This is important because it shows that this technique leads to few complications and effectively manages heart issues without impacting overall survival. Who this helps: This benefits patients with heart conditions who need defibrillators, as well as doctors who are implanting the devices.

Plain English
This study looked at patients with advanced heart failure who used both a left ventricular assist device (LVAD) and a subcutaneous implantable cardioverter defibrillator (S-ICD). Out of 30 patients, 21 experienced some degree of electromagnetic interference, but 90% remained eligible for the S-ICD. This is important because it shows that most patients can safely use both devices together, although doctors need to be cautious about potential issues related to electromagnetic interference that could affect how the devices work. Who this helps: Patients with advanced heart failure who require mechanical support for their hearts.

Plain English
This study looked at how often patients experienced worsening of tricuspid valve regurgitation (TR) after a procedure called transvenous lead extraction (TLE), which is used to remove implanted heart leads. Out of 158 patients, 5.7% had a significant increase in TR severity, especially those with longer lead implant durations and certain types of leads. This is important because severe worsening of TR can significantly raise the risk of dying, highlighting the need for doctors to be careful when performing this procedure. Who this helps: This helps patients undergoing lead extraction and their doctors by improving awareness of potential complications.

Plain English
This study looked at how the amount of a drug called propofol affects the success of defibrillation testing during the implantation of subcutaneous implantable cardioverter-defibrillators (S-ICDs). Out of 80 patients, 12 (15%) did not respond to the first shock during the test. The results showed that patients who failed the first shock received more propofol—an average of 653 mg—compared to those who succeeded, who received 376 mg. Who this helps: This information helps doctors understand how to better manage anesthesia during S-ICD procedures to improve patient outcomes.

Plain English
This study looked at patients with a heart condition called arrhythmogenic cardiomyopathy (ACM) who received a special heart device known as the third-generation subcutaneous implantable cardioverter defibrillator (S-ICD), implanted using a new two-incision technique. Over a follow-up period of about 3.8 years, only 17.4% of the patients received at least one inappropriate shock from the device, mainly due to muscle movement during physical activity, and there was just one case of device malfunction. The findings suggest that this new implantation method is effective with a low overall complication risk, although doctors need to be aware of the potential for the device to mistakenly deliver shocks during exercise. Who this helps: This benefits patients with arrhythmogenic cardiomyopathy who need heart rhythm monitoring and treatment.

Plain English
This study examined the success and safety of removing old heart leads using special tools in patients whose leads had been in place for more than 10 years. Out of 441 leads from 189 patients, 94.8% were completely removed successfully, with only 1.8% failing to be extracted and a low complication rate of 2%. These results are important because they show that lead extraction can be done safely and effectively in older patients who need it, which can improve their health and reduce complications. Who this helps: This benefits patients with old heart leads and their doctors.

Plain English
This study looked at the outcomes of a procedure called transvenous lead extraction (TLE) in patients aged 80 and older, specifically using advanced tools to help with the process. Out of 83 patients, the procedure was successful in 93.9% of cases, with a 30-day mortality rate of 6%. The findings show that, although older patients have higher risks of complications, the extraction can be done safely and effectively using specialized methods, helping doctors make better decisions about heart device removals for this age group. Who this helps: This research benefits elderly patients with heart devices, as well as their healthcare providers.

Plain English
Researchers examined a new mapping tool for heart procedures called the Octaray catheter, which has more sensors than a previously used device. In their analysis of 50 procedures involving 46 patients, they found that this catheter was safe and effective, achieving a 94% success rate in stopping heart rhythm issues. Notably, the Octaray captured more detailed heart data in less time than the older catheter, helping doctors gain better insights into heart conditions. Who this helps: This benefits patients with heart rhythm disorders and their doctors.

Plain English
This study examined the effectiveness of a specialized tool called the Evolution RL bidirectional rotational mechanical sheath for safely removing heart device leads from patients. It involved 84 patients, primarily men around 65 years old, and showed a high success rate, with 91.6% of procedures completed successfully and only 1.2% experiencing major complications. This is important because it highlights how teamwork between heart surgeons and specialists can improve patient care and outcomes, particularly for those with infections. Who this helps: This helps patients needing lead removal from heart devices, especially those with infections.

Plain English
This study explored how well a specific measurement called post-pacing interval (PPI) predicts the success of a treatment called catheter ablation for a heart condition known as atypical flutter. Researchers looked at 177 ablation procedures and found that when the PPI was less than 0 milliseconds, the chance of successfully stopping the heart's rapid rhythm was 27.8%, compared to 14.5% when it was longer (which is highly significant). Additionally, the results showed that nearly 50.6% of such cases led to a longer heart rhythm cycle at these sites, indicating that shorter PPIs might be more effective for treatment. Who this helps: This research benefits patients with atypical flutter by improving the chances of successful heart rhythm treatment.

Plain English
This study looked at how specific heart wave patterns in patients with a severe heart attack (called STEMI) can predict serious complications, like sudden heart failure (ventricular fibrillation) and death within 30 days. Researchers found that patients with a particular ECG pattern (the TW-Lambda pattern) were significantly more likely to experience these issues, with 50% of them suffering from ventricular fibrillation compared to only 8% of patients without this pattern. Understanding these patterns can help doctors quickly assess which STEMI patients are at a higher risk for severe outcomes. Who this helps: Patients experiencing STEMI and their doctors.

Plain English
This study looked at areas of the heart involved in a type of irregular heartbeat called atypical atrial flutter. Researchers found that sites where the postpacing interval (the time it takes for the heart to reset) was shorter than the heart's cycle length indicated problems within narrower areas of the heart tissue. Specifically, these sites were more common in places less than 15 mm wide and showed slower electrical conduction, which could help doctors target treatment more effectively. Who this helps: This research benefits patients with atypical atrial flutter by potentially leading to better treatment strategies.